PG Foils reported a sharp financial decline for FY 2025-26, with revenue dropping to Rs 333.93 crore and a net loss of Rs 8.24 crore. The company, which shifted its strategy toward value-added pharmaceutical packaging foils, saw EPS fall to -6.99. While annual performance struggled, management claims an improvement in the first quarter of FY 2026-27, marking a pivotal transition phase for the aluminum packaging player.
PG Foils Reports Annual Loss as Revenue Drops to Rs 333.93 Crore
PG Foils reported a net loss of Rs 8.24 crore for FY 2025-26, shifting from a Rs 24.11 crore profit in the previous year. Revenue also declined significantly to Rs 333.93 crore, down from Rs 521.06 crore in FY 2024-25.
Reader Takeaway: PG Foils pivots to value-added pharma packaging to overcome annual losses; Q1 recovery remains a key watch point.
What just happened
PG Foils has released its annual results for the year ending March 31, 2026, revealing a challenging period characterized by a bottom-line reversal into losses. The company reported a negative EPS of Rs -6.99. Despite the overall downturn, the firm managed to grow its export revenue to Rs 68.59 crore, up from Rs 56.36 crore in the prior year.
Why this matters
The transition from profit to loss indicates significant competitive pressure in the aluminum packaging market. Shareholders are currently evaluating if the company’s strategic pivot away from 'bare foil' toward 'converted foil' for the pharmaceutical sector can stabilize margins and restore profitability.
Management Commentary
Management attributed the performance to intense industry competition. However, there is optimism for the current year; the Chairman reported an improvement in financial performance during the first quarter of FY 2026-27. The company is prioritizing zero-defect quality and the development of ultra-light gauge foils to reduce reliance on imports.
Risks to watch
Investors should monitor the execution risk associated with the company’s strategic shift. As the business moves toward higher-value products, maintaining consistent growth—as claimed in the initial Q1 assessment—will be critical to justifying the transition and recovering share value.
What to track next
Watch for upcoming quarterly results to see if the recovery trend reported in Q1 FY 2026-27 is sustainable throughout the remainder of the fiscal year.
